Blood Transfusion Clinical Trial
Official title:
Contributing Factors Affecting Nurses' Practice of Safe Blood Transfusion in Surgical and Critical Care Units
| NCT number | NCT06370364 |
| Other study ID # | 25 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | December 1, 2020 |
| Est. completion date | April 30, 2021 |
| Verified date | April 2024 |
| Source | Matrouh University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Blood transfusions are an important part of nursing procedure. Nurses play a key role in safely administering blood products to patients in surgical and critical care unit
| Status | Completed |
| Enrollment | 350 |
| Est. completion date | April 30, 2021 |
| Est. primary completion date | April 30, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: Nurses - willing to participate in the study - work in surgical and critical care units - Sign a consent Exclusion Criteria: - Nurses - Work in outpatient units and other units - Did not sign a consent |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Faculty of Nursing, Matrouh University | Mersa Matruh |
| Lead Sponsor | Collaborator |
|---|---|
| Matrouh University |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Questionnaire to measure factors affecting safe blood transfusion | Factors affecting safe blood transfusion as assessed using a binary scale (Yes=1 and No=0) | one month | |
| Primary | observational checklist to measure nurses' practice of safe blood transfusion | Nurses' practice of safe blood transfusion as assessed using scoring of the practice checklist (zero score for not done, 0.5 score for incompletely done and one score for completely done). | three months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03651154 -
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections
|
N/A | |
| Completed |
NCT01136590 -
Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery
|
Phase 4 | |
| Completed |
NCT00097006 -
Retrovirus Epidemiology Donor Study-II (REDS-II)
|
N/A | |
| Completed |
NCT00005303 -
Effectiveness of AIDS Antibody Screening
|
N/A | |
| Completed |
NCT00005319 -
Epidemiologic Studies of Blood Use in the United States - SCOR in Transfusion Medicine
|
N/A | |
| Completed |
NCT00005301 -
Transfusion Safety Study (TSS)
|
N/A | |
| Completed |
NCT00000581 -
Granulocyte Transfusion Study
|
Phase 3 | |
| Completed |
NCT04089865 -
Oral Versus Intravenous Tranexamic Acid
|
Phase 4 | |
| Completed |
NCT02968654 -
TRansfusion Strategies in Acute Brain INjured Patients
|
N/A | |
| Enrolling by invitation |
NCT06019364 -
Transfusion of Whole Blood in Acute Bleeding
|
||
| Completed |
NCT04911413 -
Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery
|
Phase 4 | |
| Completed |
NCT03727230 -
RhD+ Blood Transfusion to Asian-type DEL Recipients
|
N/A | |
| Recruiting |
NCT06102590 -
Oxygen Extraction-guided Transfusion
|
N/A | |
| Completed |
NCT00400192 -
Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury
|
N/A | |
| Completed |
NCT00000593 -
Viral Activation Transfusion Study (VATS)
|
N/A | |
| Completed |
NCT05581238 -
Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.
|
||
| Completed |
NCT05627544 -
Blood Transfusion Applications in Hip Replacements
|
||
| Not yet recruiting |
NCT03429790 -
Cell Salvage During Caesarean Section (CSCS)
|
N/A | |
| Completed |
NCT00822588 -
Comparison in Need for Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back or Not
|
N/A | |
| Withdrawn |
NCT00269971 -
A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.
|
Phase 3 |